Annovis Bio, Inc.
USD1.86
+0.00 (+0.00%)
CEO
Maria L. Maccecchini
IPO Date
2020-01-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$1.88
Prev. Close
$1.86
Day Low
$1.83
Day High
$1.91
52W Low
$1.54
52W High
$5.50
Market Cap
$0.04B
Volume
0.66M
| -2.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 725.1% | -550.6% | 0.00 | 2.39 | -3.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -89.4% | -70.3% | 0.00 | 4.68 | -4.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -32.6% | -31.5% | 0.00 | 30.54 | -9.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -72.4% | -67.3% | 0.00 | 14.04 | -8.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 11.6% | -88.7% | -0.06 | 0.37 | -66.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 9.4% | -1400.2% | 0.00 | 0.09 | -59.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 9.8% | -190.5% | 0.00 | 0.73 | -61.8 |
| -2.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -55.2% | -42.3% | 0.00 | 4.60 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -33.9% | -29.0% | 0.00 | 7.65 | -1.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -23.0% | -20.7% | 0.00 | 10.68 | -0.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -63.0% | -42.1% | 0.00 | 3.59 | -3.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -178.9% | -88.0% | 0.00 | 2.66 | -2.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 286.7% | -99.5% | 0.00 | 1.24 | -3.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 31.8% | -13.7% | 0.00 | 1.60 | -29.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 286.6% | -217.6% | 0.00 | 2.39 | -2.0 |